News & Events
The latest developments in medical and technological advances in health and SCHILLER’s participation in various events.
The 2026 ESC Guidelines for the management of heart failure introduce new concepts for the classification, diagnosis, and treatment of
FEV1 is indispensable, but incomplete. The mistake is treating it like the whole patient when it is only one (important)
The 6-minute walk test (6MWT) provides a simple and practical measure of functional exercise capacity. Clinicians widely use it in
The new 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia (2026 ACC/AHA Dyslipidemia Guideline) includes important updates for the prevention
The GINA 2026 Guidelines introduce key updates in asthma management for both adult and pediatric patients, particularly around acute exacerbation
ADA compliance is becoming a central priority for hospitals and clinics across the United States. Providing equal access to healthcare
The measurement of Functional Residual Capacity (FRC) is an essential parameter to evaluate static lung volumes and identify obstructive or
SCHILLER Americas is pleased to announce a new strategic partnership with Esaote, one of the world’s leading medical imaging companies.
COVID-19 primarily affects the alveoli, as the virus targets type II pneumocytes. This can lead to abnormalities in the alveolar-capillary